Gabapentin Tablet, Film Coated
Product Images NDC 65862-524

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 65862-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Creatinine Clearance (Gabapentin Fig1)

This text looks like a formula for calculating a medical value called "Lt" using the age and weight of a patient along with their creatinine levels. However, the text is incomplete and some important information might be missing, as there are no units for the weight or creatinine values. Therefore, it's not possible to generate a useful description with this text alone.*

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Gabapentin Fig2)

The text presents a graph with the weekly mean pain scores observed in an ITT population during Study 1. The graph shows the scores for the placebo group and for the group taking Gabapentin at a dose of 300 mg per day. There is also some text indicating the names of days and people that are not relevant for the description.*

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Gabapentin Fig3)

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Gabapentin Fig4)

Not available.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

This is a graph showing the figures expressed as a difference from placebo by dosage and study for adjunctive therapy in patients 12 years of age with partial seizures. The daily dosage is shown in milligrams. No further information is given.*

FDA Label Image

Package Label-principal Display Panel (600 mg (100 Tablets Bottle))

Gabapentin Tablets, USP 600 mg is a medication distributed by Aurohindo Pharma USA, Inc. The tablets are made in India and contain Gabapentin USP at 600 mg. The usual dosage is mentioned in the package insert. The NDC of the medication is 65862-523-01. The medication is available only on prescription. The package has a separate medication guide for each patient. The code for the medication is TS/DRUGS/22/2009. The text does not contain any non-English characters.*

FDA Label Image

Package Label-principal Display Panel (800 mg (100 Tablets Bottle))

Gabapentin Tablets, USP are a medication available by prescription only. Each tablet has 800mg of Gabapentin USP and is sold in a bottle of 100 tablets. The medication guide provided separately should be given to each patient. The product is distributed by Aurobindo Pharma USA, Inc. and made in India. Store at 20° to 25°C (68° to 77°F). See package insert for full prescribing information. The code is TS/DRUGS/22/2009.*

FDA Label Image

Chemical Structure (Gabapentin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.